Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07373444

Westlake Aging Cohort (WeAC)

Westlake Aging Cohort

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
2,800 (estimated)
Sponsor
Westlake University · Academic / Other
Sex
All
Age
55 Years – 90 Years
Healthy volunteers
Accepted

Summary

The Westlake Ageing Cohort (WeAC) is a longitudinal cohort study conducted in Hangzhou, Zhejiang Province, China. The investigators aim to enroll 2,800 participants aged 55 years and older for long-term follow-up. The population will include individuals with neurodegenerative diseases or those at the prodromal stage of cognitive impairment, as well as healthy middle-aged and older adults serving as controls. The investigators will collect their sociodemographic, dietary, lifestyle, clinical, and neuroimaging data, as well as biological samples.

Detailed description

The investigators will recruit middle-aged and aged participants, including healthy controls and individuals with neurodegenerative disorders such as mild cognitive impairment (MCI), Alzheimer's disease (AD), Parkinson's disease dementia (PDD), and dementia with Lewy bodies (DLB), etc. The aim of this study is to construct a longitudinal database that includes sociodemographic, lifestyle, clinical, neuroimaging, and multi-omics data. This database will be used to characterize the molecular signatures of neurodegenerative disorders. In addition, the investigators will identify biomarkers associated with neurodegenerative diseases. Furthermore, the investigators aim to uncover the mechanisms underlying the progression of mild cognitive impairment (MCI) and other neurodegenerative disorders.

Conditions

Timeline

Start date
2026-01-01
Primary completion
2030-12-31
Completion
2031-12-31
First posted
2026-01-28
Last updated
2026-01-28

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07373444. Inclusion in this directory is not an endorsement.